-
-
Call more information
660-596-2224 -
Author: Layne Bettini, M.D., J.D. ASA Monitor 03 2018, Vol.82, 56-57. Layne Bettini, M.D., J.D., is a CA-1 resident, Mayo Clinic, Rochester, Minnesota. In the medical profession, the idea of lawyers spawns a litany of thoughts – few of them good. During my medical training, I took a slight detour and attended law school. When I emerged […]
Read MoreASA Monitor 03 2018, Vol.82, 40-41. Review of unusual patient care experiences is a cornerstone of medical education. Each month, the AQI-AIRS Steering Committee abstracts a patient history submitted to the Anesthesia Incident Reporting System (AIRS) and authors a discussion of the safety and human factors challenges involved. Real-life case histories often include multiple clinical decisions, […]
Read MoreAuthor: RICHARD HARRIS Rosemary Grant is a registered nurse and helps coordinate sepsis care at Harborview Medical Center in Seattle. The center’s goal, she says, is to get a patient who might be developing sepsis antibiotics within three hours. A quarter of a million Americans die every year from sepsis, which is the body’s reaction […]
Read MoreAuthors: Stavros G. Memtsoudis, M.D., Ph.D., F.C.C.P. et al Anesthesiology March 2018. Background: Multimodal analgesia is increasingly considered routine practice in joint arthroplasties, but supportive large-scale data are scarce. The authors aimed to determine how the number and type of analgesic modes is associated with reduced opioid prescription, complications, and resource utilization. Methods: Total hip/knee arthroplasties (N = […]
Read MoreAuthors: Mark van den Boogaard, PhD et al JAMA. 2018;319(7):680-690. Key Points Question What is the effect of prophylactic haloperidol on survival among critically ill adults? Findings In this multicenter randomized trial involving 1789 critically ill patients at high risk of delirium, the median number of days patients survived in 28 days was 28 days in the 2-mg haloperidol group […]
Read More